Target intelligence / Profile preview

Huntingtin mRNA (Htt1a transcript) (Htt1a mRNA)

Target
Htt1a mRNA
Molecular classification
Messenger RNA, RNA transcript
01

Overview

The Htt1a transcript is a truncated messenger RNA (mRNA) isoform of the Huntingtin (HTT) gene, generated by the aberrant retention of intron 1 during splicing. This transcript is a critical therapeutic target in Huntington's disease (HD) because it is translated into a highly toxic exon 1 HTT protein fragment that serves as a primary seed for pathogenic protein aggregation. siRNA-634 and siRNA-486 are experimental small interfering RNAs designed to selectively bind and degrade the Htt1a mRNA through the RNA interference (RNAi) pathway. By specifically targeting this truncated transcript, these siRNAs aim to reduce the burden of toxic protein species while potentially sparing the expression of the essential full-length HTT protein. Recent studies in knock-in mouse models suggest that silencing Htt1a is more effective at preventing hippocampal neurodegeneration and transcriptional dysfunction than targeting the full-length HTT mRNA alone.

Other names
HTT exon 1 transcriptIntron 1-retained HTT transcriptTruncated Huntingtin mRNAHtt1aHTT1a
02

Mechanism of action

RNA interference (RNAi) mediated degradation of the Htt1a transcript to inhibit the production of toxic exon 1 Huntingtin protein.

03

Biological functions

Protein synthesisRNA processingNeurodegeneration
04

Disease associations

Huntington's diseaseNeurodegenerative disease
05

Safety considerations

Off-target effects of siRNAsCNS delivery challengesPotential silencing of wild-type HTT protein
06

Interacting drugs

siRNA-634

1 more in the full profile.

07

Biomarkers

Htt1a transcript levelsHuntingtin protein aggregates (mHTT)Neurofilament light chain (NfL)

Beyond the preview

Go deeper on Huntingtin mRNA (Htt1a transcript) (Htt1a mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huntingtin mRNA (Htt1a transcript) (Htt1a mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call